Mason Street Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-19,991
| Closed | -$4.25M | – | 986 |
|
|
2020
Q4 | $4.25M | Sell |
19,991
-361
| -2% | -$72K | 0.07% | 280 |
|
|
2020
Q3 | $3.49M | Sell |
20,352
-301
| -1% | -$55.6K | 0.07% | 294 |
|
|
2020
Q2 | $3.96M | Buy |
20,653
+138
| +0.7% | +$22.6K | 0.08% | 223 |
|
|
2020
Q1 | $3.02M | Hold |
20,515
| – | – | 0.07% | 266 |
|
|
2019
Q4 | $3.18M | Buy |
20,515
+47
| +0.2% | +$6.77K | 0.06% | 360 |
|
|
2019
Q3 | $2.77M | Buy |
20,468
+18
| +0.1% | +$2.36K | 0.06% | 392 |
|
|
2019
Q2 | $2.5M | Buy |
20,450
+6
| +0% | +$665 | 0.05% | 436 |
|
|
2019
Q1 | $2.13M | Buy |
20,444
+354
| +2% | +$36.5K | 0.04% | 542 |
|
|
2018
Q4 | $2.29M | Buy |
20,090
+24
| +0.1% | +$2.57K | 0.06% | 394 |
|
|
2018
Q3 | $2.31M | Buy |
20,066
+40
| +0.2% | +$4.38K | 0.05% | 473 |
|
|
2018
Q2 | $2.07M | Buy |
20,026
+117
| +0.6% | +$11.8K | 0.05% | 526 |
|
|
2018
Q1 | $1.96M | Buy |
19,909
+143
| +0.7% | +$13.5K | 0.04% | 537 |
|
|
2017
Q4 | $1.67M | Buy |
19,766
+25
| +0.1% | +$2.06K | 0.04% | 642 |
|
|
2017
Q3 | $1.52M | Sell |
19,741
-49,537
| -72% | -$3.79M | 0.04% | 665 |
|
|
2017
Q2 | $5.39M | Buy |
69,278
+2,357
| +4% | +$169K | 0.14% | 135 |
|
|
2017
Q1 | $4.82M | Buy |
66,921
+1,129
| +2% | +$78K | 0.12% | 144 |
|
|
2016
Q4 | $4.08M | Buy |
65,792
+692
| +1% | +$42.4K | 0.11% | 178 |
|
|
2016
Q3 | $4.22M | Buy |
65,100
+1,068
| +2% | +$71.1K | 0.12% | 164 |
|
|
2016
Q2 | $4.05M | Buy |
64,032
+3,058
| +5% | +$180K | 0.12% | 161 |
|
|
2016
Q1 | $3.53M | Buy |
60,974
+2,482
| +4% | +$140K | 0.11% | 185 |
|
|
2015
Q4 | $3.14M | Buy |
58,492
+710
| +1% | +$40K | 0.1% | 219 |
|
|
2015
Q3 | $2.94M | Buy |
57,782
+664
| +1% | +$35.7K | 0.1% | 225 |
|
|
2015
Q2 | $3.22M | Buy |
57,118
+509
| +0.9% | +$32.1K | 0.1% | 220 |
|
|
2015
Q1 | $4.06M | Sell |
56,609
-13,073
| -19% | -$849K | 0.12% | 166 |
|
|
2014
Q4 | $3.91M | Sell |
69,682
-1,208
| -2% | -$63.1K | 0.03% | 652 |
|
|
2014
Q3 | $3.49M | Buy |
70,890
+507
| +0.7% | +$25.8K | 0.03% | 665 |
|
|
2014
Q2 | $3.56M | Sell |
70,383
-2,318
| -3% | -$115K | 0.03% | 681 |
|
|
2014
Q1 | $3.25M | Sell |
72,701
-371
| -0.5% | -$16.7K | 0.03% | 715 |
|
|
2013
Q4 | $3.44M | Sell |
73,072
-598
| -0.8% | -$30.3K | 0.03% | 674 |
|
|
2013
Q3 | $3.89M | Sell |
73,670
-10,230
| -12% | -$496K | 0.04% | 436 |
|
|
2013
Q2 | $3.79M | Buy |
+83,900
| New | +$3.98M | 0.04% | 471 |
|
Other funds holding RMD
Mason Street Advisors's RMD Position: Q1 2021 in Review
Mason Street Advisors sold out of ResMed (RMD) in Q1 2021, closing a stake of 19,991 shares — an estimated $4.25M sold.
Mason Street Advisors first reported a position in RMD in Q2 2013 and held it in 31 quarters. The position peaked at $5.39M in Q2 2017. 663 funds tracked by Wall St. Rank hold RMD as of Q1 2021.
- Mason Street Advisors reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 19,991 ResMed shares in Q1 2021, an estimated $4.25M.
- Mason Street Advisors first reported a position in ResMed in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's ResMed position peaked at $5.39M in Q2 2017.
- 663 funds tracked by Wall St. Rank held ResMed as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.